{"id":"clm_AC822552ABB6","entity":"amgen","predicate":"cash_and_equivalents","value":"2,896,000,000 United States dollar","value_json":{"fp":"Q1","fy":2016,"accn":"0000318154-16-000035","form":"10-Q","filed":"2016-05-02","period":"Q1 FY2016","concept":"us-gaap:CashAndCashEquivalentsAtCarryingValue"},"valid_from":"2016-03-31","valid_to":"2016-06-30","published":"2016-05-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Amgen cash and equivalents: 2,896,000,000 United States dollar\", as of 2016-03-31 (until 2016-06-30). Claim clm_AC822552ABB6, https://asof.is/claim/clm_AC822552ABB6, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/318154/000031815416000035/0000318154-16-000035-index.htm.","url":"https://asof.is/claim/clm_AC822552ABB6","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_E0A3DD098E3C","supersedes":["clm_62DBA6442A89"],"first_seen_at":"2026-11-08T15:38:26.099962+00:00","updated_at":"2026-11-08T15:38:34.205395+00:00","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815416000035/0000318154-16-000035-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2016","published_at":"2016-05-02T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2016, filed 2016-05-02"},"legend":{"dates":"valid_from: when the claim took effect (a period figure: the day its period closed). published: the earliest day a source on the record published it (a filing's filing date, a post's date; null when no source carries one). recorded: the day AsOf first held it. A figure can take effect weeks before it is published.","citation":"citation: how to cite the row (plain: one sentence with the value, its as-of date, the claim id and URL, the day answered and the primary source; url: the claim page; accessed: the day answered). APA and BibTeX forms are on the claim page.","why_not":{},"checked_by":{"sec-filing":"parsed from the SEC filing"}}}